A randomized double-blind placebo-controlled study of ALPN-101 in systemic lupus erythematosus.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Systemic Lupus Erythematosus
  • Age: Between 18 Year(s) - 65 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Diagnosis of SLE for greater than or equal to 6 months prior to Screening
    2. Subjects must have anti-nuclear antibodies (ANA) and/or elevated anti-dsDNA and/or elevated anti-Smith antibody test at Screening
    3. Subjects must

You may not be eligible for this study if the following are true:

    1. Life-threatening or organ system-threatening SLE activity that is sufficiently active that it is expected to require increase in treatment during the study
    2. Proteinuria consistent with nephrotic syndrome
    3. Active lupus-rel

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.